These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12665544)

  • 1. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.
    Berglund MM; Schober DA; Statnick MA; McDonald PH; Gehlert DR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):147-56. PubMed ID: 12665544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chicken neuropeptide Y-family receptor Y4: a receptor with equal affinity for pancreatic polypeptide, neuropeptide Y and peptide YY.
    Lundell I; Boswell T; Larhammar D
    J Mol Endocrinol; 2002 Jun; 28(3):225-35. PubMed ID: 12063188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
    Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
    Goumain M; Voisin T; Lorinet AM; Laburthe M
    Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation.
    Kilpatrick LE; Briddon SJ; Hill SJ; Holliday ND
    Br J Pharmacol; 2010 Jun; 160(4):892-906. PubMed ID: 20438572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation.
    Berglund MM; Schober DA; Esterman MA; Gehlert DR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1120-6. PubMed ID: 14551289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
    Ouedraogo M; Lecat S; Rochdi MD; Hachet-Haas M; Matthes H; Gicquiaux H; Verrier S; Gaire M; Glasser N; Mély Y; Takeda K; Bouvier M; Galzi JL; Bucher B
    Traffic; 2008 Mar; 9(3):305-24. PubMed ID: 18088318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
    Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
    Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY.
    Bard JA; Walker MW; Branchek TA; Weinshank RL
    J Biol Chem; 1995 Nov; 270(45):26762-5. PubMed ID: 7592911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor.
    Parker SL; Kane JK; Parker MS; Berglund MM; Lundell IA; Li MD
    Eur J Biochem; 2001 Feb; 268(4):877-86. PubMed ID: 11179953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes.
    Sundström G; Xu B; Larsson TA; Heldin J; Bergqvist CA; Fredriksson R; Conlon JM; Lundell I; Denver RJ; Larhammar D
    Gen Comp Endocrinol; 2012 Jul; 177(3):322-31. PubMed ID: 22565163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women.
    Dumont Y; Bastianetto S; Duranton A; Breton L; Quirion R
    Peptides; 2015 Aug; 70():7-16. PubMed ID: 26002416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.